Latest news Stephen Harrison at The Liver Meeting 2019. Photo by Liz Highleyman.Experimental treatments for NASH/NAFLDNew NASH therapies show promise in mid-stage studies. News from The Liver Meeting 2019Visit our conference news page. Hepatitis news bulletinSign up for our monthly hepatitis news bulletin. infohep news Hepatocellular carcinoma (HCC) Immunotherapy combination improves liver cancer survival Liz Highleyman / 27 November 2019 A combination of nivolumab (Opdivo) and ipilimumab (Yervoy), two different types of checkpoint inhibitor immunotherapy, led to higher response rates and longer survival than nivolumab alone in people with advanced liver cancer, according to a ... Experimental treatments for NASH/NAFLD New NASH therapies show promise in mid-stage studies Liz Highleyman / 26 November 2019 Phase II study results presented at the AASLD Liver Meeting this month in Boston show that a number of experimental therapies improve markers of liver health in people with non-alcoholic steatohepatitis (NASH). ... View all infohep news Editors' picks from other sources Malaysia: Stage set for access to Hepatitis C treatment Star Online / 13 November 2019 Greggs vouchers offered to encourage drug users to get tested for hepatitis C Pharmaceutical Journal / 13 November 2019 Roche takes aim at hepatitis B, striking R&D deal with Dicerna Biopharma Dive / 12 November 2019 View all news from other sources Conference news More conference news Noticeboard ILC 2016 webinar: watch again More noticeboard posts Email updates Sign up for our monthly bulletins Sign up today Other pages in this section Latest news All the news Conference news Noticeboard Email bulletins News feeds